Indeed, we have previously demonstrated that ATM is required for DNA damage-induced activation of p65/p50 in breast cancer cells [7], and in CLL cells ATM interacts with the TCL1 oncogene to activate NF-κB [8]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.